Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology (Drs Oakes, Kernberg, Carter, Foeller, Raghuraman, and Kelly).
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology (Drs Oakes, Kernberg, Carter, Foeller, Raghuraman, and Kelly).
Am J Obstet Gynecol MFM. 2021 May;3(3):100319. doi: 10.1016/j.ajogmf.2021.100319. Epub 2021 Jan 22.
As of November 18, 2020, more than 11 million people have been infected with coronavirus disease 2019 and almost 250,000 people have died from the disease in the United States, less than 1 year since its discovery. Although literature is beginning to emerge on pregnancy as a risk factor for severe coronavirus disease 2019, these studies are heterogeneous and use primary outcomes such as intensive care unit admission or hospitalization as surrogate markers that may subject analyses to misclassification bias in pregnant patients.
This study aimed to determine the risk of severe coronavirus disease 2019 among pregnant women with symptomatic coronavirus disease 2019 compared with nonpregnant women using nonadmission-based, standardized clinical criteria for severe disease.
This is a retrospective cohort study of women aged 13 to 45 years and diagnosed as having symptomatic coronavirus disease 2019 between May 28, 2020, and July 22, 2020. The primary outcome was severe coronavirus disease 2019 as defined by 2 sets of nonadmission-based, clinical criteria: the World Health Organization Ordinal Scale for Clinical Improvement and the Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Adjusted risk ratios were estimated using multivariable logistic regression analyses.
Of 262 women aged 13 to 45 years with symptomatic coronavirus disease 2019, 22 (8.4%) were pregnant and 240 (91.6%) were nonpregnant. After adjusting for covariates potentially associated with the primary outcome, symptomatic pregnant women were at a significantly increased risk of severe coronavirus disease 2019 compared with nonpregnant women using both the World Health Organization Ordinal Scale for Clinical Improvement (adjusted relative risk, 3.59; 95% confidence interval, 1.49-7.01) and Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (adjusted relative risk, 5.65; 95% confidence interval, 1.36-17.31) criteria.
Pregnancy significantly increases the risk of severe coronavirus disease 2019 as defined by nonadmission-based, clinical criteria.
截至 2020 年 11 月 18 日,美国已有超过 1100 万人感染 2019 冠状病毒病,近 25 万人死于该疾病,这是该疾病发现不到 1 年后的数据。尽管有关妊娠是 2019 冠状病毒病重症的危险因素的文献开始出现,但这些研究存在异质性,并且使用重症监护病房收治或住院等主要结局作为替代标志物,这可能使分析存在对妊娠患者的分类偏倚。
本研究旨在使用非入院的标准化临床重症标准,确定有症状的 2019 冠状病毒病孕妇与非孕妇相比发生重症 2019 冠状病毒病的风险。
这是一项回顾性队列研究,纳入 2020 年 5 月 28 日至 2020 年 7 月 22 日期间年龄在 13 至 45 岁之间且被诊断为有症状的 2019 冠状病毒病的女性。主要结局为使用 2 套非入院的临床标准定义的重症 2019 冠状病毒病:世界卫生组织临床改善等级量表和新型冠状病毒肺炎应急响应流行病学组。使用多变量逻辑回归分析估计调整后的风险比。
在 262 名年龄在 13 至 45 岁之间有症状的 2019 冠状病毒病患者中,有 22 名(8.4%)为孕妇,240 名(91.6%)为非孕妇。调整可能与主要结局相关的协变量后,与非孕妇相比,有症状的孕妇患重症 2019 冠状病毒病的风险显著增加,这两种情况均使用世界卫生组织临床改善等级量表(调整后的相对风险,3.59;95%置信区间,1.49-7.01)和新型冠状病毒肺炎应急响应流行病学组(调整后的相对风险,5.65;95%置信区间,1.36-17.31)标准。
使用非入院的临床标准,妊娠显著增加了重症 2019 冠状病毒病的风险。